Elixie
Nano-Tech Cannabinoid products
StartupElixie is a Caesarea-based startup in the Health Tech & Life Sciences sector, established in 2019. Nano-Tech Cannabinoid products. The company has raised a total of $2M across 1 funding round, currently at the Seed stage. Elixie was founded by Yaron Shoob. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
With $2M in total funding, Elixie is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B2C, B2B
- Employees1-10
- HQCaesarea
- DistrictCenter District
- Last Round$2M
Yaron ShoobCo-founder & CEO
What does Elixie do?
Elixie is a clinical-stage biotech company enhancing cannabinoids for symptomatic relief of neurological disorders based on NANOLIX, a patented clinically proven Self-nano emulsifying drug delivery system (SNEDDS). By encapsulating validated APIs in in-human-proven NANOLIX and targeting orphan diseases, Elixie will register pharmaceuticals in a relatively short route to market and with minimal risks.
How much funding has Elixie raised?
Elixie has raised $2M in total funding across 1 rounds. The company is currently at the Seed stage.
Who founded Elixie?
Elixie was founded in 2019 by Yaron Shoob (Co-founder & CEO ).
What sector is Elixie in?
Elixie operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, Drug Delivery, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Patients.
Where is Elixie located?
Elixie is based in Tarshish Industrial Park St 5, Caesarea, Israel, Center District.